发明名称 Indirubin-3′-oxime derivatives as potent cyclin dependent kinase inhibitors
摘要 The present invention relates to an indirubin-3′-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3′-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and/or human breast cancer cell.
申请公布号 US8859783(B2) 申请公布日期 2014.10.14
申请号 US201113576105 申请日期 2011.01.28
申请人 Anygen Co., Ltd. 发明人 Kim Yong-Chul;Kim Jae-Il;Ban Soo-Ho;Jeong Soon-Young;Choi Soo-Jeong;Lee Jung-Eun
分类号 C07D209/38;A61K31/404;C07D403/04 主分类号 C07D209/38
代理机构 Kenyon & Kenyon LLP 代理人 Kenyon & Kenyon LLP
主权项 1. An indirubin-3′-oxime derivative compound as cyclin dependent kinase inhibitor represented by formula (I) wherein i) R1 is OH and R2 is NO2; ii) R1 is F and R2 is NO2; iii) R1 is OH and R2 is Cl; or iv) R1 is OH and R2 is F.
地址 Jeollanam-Do KR